OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10368	Companies
215992	Keywords
145726	Articles
114383	Press releases

Home
Companies
OXURION

BRIEF

published on 06/18/2025 at 18:05, 10 months 19 days ago

Oxurion Announces Transparency Notification from Atlas Special Opportunities II LLC

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ownership Structure Oxurion
BRIEF

published on 06/18/2025 at 18:05, 10 months 19 days ago

Oxurion annonce une notification de transparence de la part d'Atlas Special Opportunities II LLC

Biopharmaceutique Notification De Transparence Oxurion Opportunités Spéciales Atlas Structure De Propriété
PRESS RELEASE

published on 06/18/2025 at 18:00, 10 months 19 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding shareholding. Company combines therapeutic innovation with technology for clinical research

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
PRESS RELEASE

published on 06/18/2025 at 18:00, 10 months 19 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC, verlaagt aandeel tot onder drempel 20%. Biofarmaceutisch bedrijf in Leuven kondigt belangrijke ontwikkeling aan

Transparantiekennisgeving Oxurion NV Biofarmaceutisch België Atlas Special Opportunities II LLC
BRIEF

published on 06/12/2025 at 18:05, 10 months 25 days ago

Oxurion Reports Transparency Notification Amendments

Transparency Notification Biopharmaceutical Industry Shareholding Changes Oxurion NV Atlas Special Opportunities II
BRIEF

published on 06/12/2025 at 18:05, 10 months 25 days ago

Oxurion annonce des modifications à sa notification de transparence

Industrie Biopharmaceutique Notification De Transparence Oxurion NV Changements Dans L'actionnariat Atlas Opportunités Spéciales II
PRESS RELEASE

published on 06/12/2025 at 18:00, 10 months 25 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding its share ownership crossing thresholds under Belgian Transparency legislation. Oxurion is a biopharmaceutical company focusing on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Oxurion NV Belgian Legislation
PRESS RELEASE

published on 06/12/2025 at 18:00, 10 months 25 days ago

Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aankoop en verkoop van aandelen en stemrechtverlenende effecten volgens Belgische transparantiewetgeving

Transparantiekennisgevingen Aandelen Oxurion NV Belgische Transparantiewetgeving Atlas Special Opportunities II LLC
BRIEF

published on 06/12/2025 at 08:35, 10 months 25 days ago

Oxurion progresse dans son acquisition d'Axiodis

Acquisition Sciences De La Vie Oxurion Axiodis FDI France
BRIEF

published on 06/12/2025 at 08:35, 10 months 25 days ago

Oxurion progresses in its acquisition of Axiodis

Acquisition Life Sciences Oxurion Axiodis FDI France

Accesswire

Published on 05/08/2026 at 01:50, 5 hours 38 minutes ago

Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 6 hours 43 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 7 hours 28 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 7 hours 58 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 8 hours 13 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting

View all ACCESSWIRE

EQS Group

Published on 05/08/2026 at 07:05, 23 minutes ago

Coway Announces Financial Results for Q1 FY2026
Published on 05/08/2026 at 06:45, 43 minutes ago

Krones starts financial year with strong order intake and confirms financial targets for 2026
Published on 05/08/2026 at 06:40, 48 minutes ago

Jungfraubahn Holding AG: Jungfrau Railway Group: After a subdued start to 2026, this trend is becoming more pronounced
Published on 05/08/2026 at 06:30, 58 minutes ago

Interroll Holding AG announces the acquisition of Royal Apollo Group
Published on 05/08/2026 at 06:30, 58 minutes ago

Lonza Delivers Strong Performance in Q1 2026 in Line with Expectations and Confirms Full-Year Outlook 2026

Les Echos

Published on 05/07/2026 at 19:15, 12 hours 13 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 12 hours 13 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 12 hours 22 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 12 hours 22 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 12 hours 28 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE